Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|March 1, 1990
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantationE Gluckman, I Jolivet, M L Scrobohaci, et al.Bone Marrow Transplantation|June 1, 1995
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host diseaseM Moussalem, H Esperou Bourdeau, A Devergie, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Allogenic bone marrow grafts in chronic myeloid leukemia]A Devergie, E Gluckman, F Varrin, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Collection of placental blood with a view to hemopoietic reconstitutionY Brossard, J Van Nifterik, V De Lachaux, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot studyP Lehn, A Quessar, A Devergie, et al.Bone Marrow Transplantation|February 16, 2000
Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunizationS Bellucci, G Damaj, B Boval, et al.Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.British Journal of Haematology|August 14, 2008
Double cord blood transplantation in patients with high risk bone marrow failure syndromesA Ruggeri, R Peffault de Latour, V Rocha, et al.Cytotherapy|September 6, 2007
Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 graftsV Vanneaux, E Foïs, M Robin, et al.Bone Marrow Transplantation|April 25, 2001
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaR Morariu-Zamfir, V Rocha, A Devergie, et al.Pageof 4